Volumetric

Volumetric, founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, is a pioneering company in the field of 3D bioprinting. The company's core mission is to build living multicellular tissues that replicate discrete functions of the human body, with applications in mechanistic biology, laboratory testing, screening, and drug development. Volumetric's ultimate vision is to create whole human organ replacements made from patients' own cells, significantly advancing personalized medicine.

Notable figures affiliated with Volumetric include its co-founders, Bagrat Grigoryan and Jordan Miller, who are recognized leaders in the bioprinting field. The company has garnered attention for its innovative technology and approach, leading to significant achievements in creating functional human tissues. Volumetric's impact extends to improving drug testing accuracy and paving the way for future organ replacement therapies, positioning it as a key player in the biotechnological and medical sectors.